awesome song day! is a spontaneous feature, when i am moved by a song's singular awesomeosity and feel the urge to share its awesomeness with all of you. the song below is awesome.
if there is one thing i wish indie rockers would learn from hip hop divas (and nas, who is not a diva), it's how to pull off a diss track. i would love nothing more than to have massive indieland feuds (a dream matchup would be team love and southern lord) and bands writing songs about how much the new vampire weekend sucks (yeah, you weren't actually expecting me to like a buzz band, were you?). i'm not sure if "cassius" really falls into the "diss track" category, since it's unclear whether frontman yannis philippakis is singing about this french band, but i'd like to imagine that he is, especially when he sings "cassius it's over /you're second best second best second best second best." sounds like a diss track to me, and it fits into the pre-existing anglo-franco conflict. as a proud supporter of scotland (as if you couldn't guess, right?), i just want to say: go france!
seriously though, cassius does kinda suck. check it.
even if the idea of an electropunk diss track doesn't appeal to you, you should like this song anyway. it's all elbows and sharp guitars and groovy post-dance beats and too-skinny jeans. sounds like the perfect recipe for success, doesn't it? hmmm...didn't i say i don't like buzz bands? at least foals has an original sound, instead of ripping off paul simon.
foals play bowery ballroom on 2/12 (who has no thumbs and his ticket for this already? mr. mammoth) with also-awesome team robespierre. they then play silent barn (915 wyckoff in ridgewood) with tba guests on the 13th, and chop suey in seattle on the 14th. those are their only american dates. hope cassius don't show up for their 4 dates in france/see other (mostly sold-out) tour dates at their myspace.
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaand, you can get more live traxxxxx (it's funny, because foals have a song called "xxxxx") at the fan-run foals band dot com.
foals' debut antidotes is due april 8 on